A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer
A Comparison of Paclitaxel in Combination With Cisplatin(TP), Carboplatin(TC) or Fluorouracil(TF) Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Squamous Cell Carcinoma: A Three-Arm Randomized Phase III Trial
Sponsor: Fudan University
This PHASE3 trial investigates Stage III Esophageal Squamous Cell Carcinoma and is currently completed. Fudan University leads this study, which shows 12 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE3
▶ Show 7 earlier versions
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Nov 2019 — Jun 2020 [monthly]
Active Not Recruiting PHASE3
-
Jul 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Jul 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE3
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Dec 2017 [monthly]
Recruiting PHASE3
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
- Gansu Cancer Hospital
- Huadong Hospital
- Jiangsu Cancer Institute & Hospital
- Jiangxi Provincial Cancer Hospital
- Shanxi Province Cancer Hospital
- The First Affiliated Hospital of Xiamen University
- Wuxi No. 4 People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .